CoChat

Protonitazene detection in two cases of opioid toxicity following the use of tetrahydrocannabinol vape products in Australia

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

Introduction Protonitazene is an opioid belonging to the 2-benzylbenzimidazole structural class. We describe two cases of opioid toxicity involving the reported inhalation of a delta-9-tetrahydrocannabinol vape product in which protonitazene was detected.Case reports Case 1 was a young male found unconscious after the reported use of a delta-9-tetrahydrocannabinol vape. He suffered two subsequent apnoeic episodes requiring bag-valve-mask ventilation before eventual recovery. Only protonitazene was detected in blood at a concentration of 0.74 µg/L. Case 2 was a young male who died shortly after being found unresponsive. The postmortem femoral blood concentrations of protonitazene and delta-9-tetrahydrocannabinol were 0.33 µg/L and 2 µg/L, respectively. Analysis of a pod vaping device found in the decedent’s hand and a separate e-liquid bottle labelled as delta-9-tetrahydrocannabinol showed a mixture of protonitazene and delta-9-tetrahydrocannabinol.Discussion The opioid effects of protonitazene are mediated through β-arrestin2 and mu opioid receptor signalling pathways. Benzimidazole opioids are lipophilic and, when mixed with a suitable solvent, can be used in a vape device. It is anticipated that naloxone would have provided effective reversal of toxicity in our cases.Conclusions Novel routes of opioid administration, like vaping, may appear relatively innocuous in comparison to intravenous administration, but opioids may still be absorbed at high concentrations, resulting in severe opioid toxicity or death.

Overview

Integrity signals

Registry

Crossref · 10.1080/15563650.2024.2383692

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 7 references

Research works printed but not linked: 1

  1. The World Health Organisation. Critical review report: protonitazene. Expert Committee on Drug Dependence. Geneva, Switzerland: The World Health Organisation; 2022. p. 16.

Cited by

See all 19

Metadata

Authors
Syrjanen, R., Schumann, J. L., Castle, J. W., Sharp, L., Griffiths, A., Blakey, K., Dutch, M., Maplesden, J., & Greene, S. L.
Affiliations
  • Austin Hospital (AU)
  • Victorian Institute of Forensic Medicine (AU)
  • Forensic Toxicology, Forensic and Scientific Services, Coopers Plains, Australia
  • Forensic Chemistry, Forensic Science Queensland, Coopers Plains, Australia
  • The University of Melbourne (AU)
  • St Vincent's Hospital Melbourne (AU)
Corresponding author
Greene, Shaun L.
Venue
Clinical Toxicology
Published
2024-07-30
Volume
62
Issue
8
Pages
539-541
ISSN
  • 0009-9309 (ISSN-L)
  • 1556-3650
  • 1556-9519
OpenAlex
W4401121511
Cited by
19
References
7
Citations by year
2026: 9 · 2025: 9 · 2024: 1
FWCI
4.50
Type
journal article
Language
en
Open access
closed
Locations
  • Clinical Toxicology (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Victorian Department of Health
  • the National Health and Medical Research Council (GNT2001107)
Topics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Forensic Toxicology and Drug Analysis
  • Health Sciences › Medicine › Emergency Medicine › Poisoning and overdose treatments
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
Keywords
opioid toxicity, vaping, delta-9-tetrahydrocannabinol, β-arrestin2, mu-opioid receptor, naloxone, postmortem toxicology, apnea
MeSH terms
Vaping, Adult, Analgesics, Opioid, Australia, Benzimidazoles, Humans, Indazoles, Male, Dronabinol, Valine, Fatal Outcome, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Protonitazene detection in two cases of opioid toxicity following the use of tetrahydrocannabinol vape products in Australia. https://app.cochat.ai/papers/10.1080/15563650.2024.2383692
The paper
Syrjanen, R., Schumann, J. L., Castle, J. W., Sharp, L., Griffiths, A., Blakey, K., Dutch, M., Maplesden, J., & Greene, S. L. (2024). Protonitazene detection in two cases of opioid toxicity following the use of tetrahydrocannabinol vape products in Australia. Clinical Toxicology. https://doi.org/10.1080/15563650.2024.2383692

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.